While the measles vaccine induces robust CD4+ and CD8+ T cell responses in infants (>6 months) and adults, the CD4+ and CD8+ T cell responses are yet to be examined for the MV-ZIKA dual antigen vaccines66. Here, CD4 is linked to measles.